SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4%),Takeda Ventures, Inc(4%)
武田製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4.8%)
武田製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(5.4%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(7.7%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Sumitomo Mitsui Trust Holdings, Inc.(5.5%)
武田製藥 | 4:持股變動聲明-股東 TAKEDA PHARMACEUTICAL CO LTD
武田製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(6.6%)
武田製藥 | SC 13G:超過5%持股股東披露文件-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)
武田製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(0.0%),Takeda Ventures, Inc(0.0%)
武田製藥 | 4:持股變動聲明-其他相關方 TAKEDA PHARMACEUTICAL CO LTD
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(7.2%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(0%),Takeda Ventures, Inc.(0%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Ventures, Inc(0%),Takeda Pharmaceutical Company Limited(0%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(12.2%),Takeda Pharmaceuticals U.S.A., Inc(9.8%)
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Sumitomo Mitsui Trust Holdings, Inc.(5.9%)
武田製藥 | 4:持股變動聲明
武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4.96%),Takeda Ventures, Inc(4.96%)
武田製藥 | 4:持股變動聲明
武田製藥 | 4:持股變動聲明
武田製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(15.00%),Takeda Ventures, Inc(15.00%)
暫無數據